HERZLIYA, Israel, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Frutarom Industries Ltd. ("Frutarom"), one of the world's 10 largest companies in the field of flavors and natural specialty fine...
MIGDAL HA’EMEQ, Israel, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY) (“Enzymotec” or the “Company”), a developer, manufacturer and marketer of innovative bio-active lipid...
MIGDAL HA’EMEQ, Israel, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional...
MIGDAL HA’EMEQ, Israel, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY) (the “Company”), today announced that it will hold its 2017 Annual and Extraordinary General Meeting of...
FRUTAROM CONTINUES TO ESTABLISH ITSELF AS ONE OF THE WORLD’S TEN TOP COMPANIES IN ITS FIELD AND ANNOUNCES ITS NINTH ACQUISITION IN 2017 FOLLOWING ITS ACCELERATED INTERNAL GROWTH AND...
MIGDAL HA’EMEQ, Israel, Oct. 29, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional...
MIGDAL HA'EMEQ, Israel, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional...
MIGDAL HA’EMEQ, Israel, Aug. 28, 2017 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) today responded to the unsolicited proposal from Frutarom Ltd. to acquire Enzymotec for $11.50 per...
ANNOUNCES ITS INTENTION TO MAKE A FULL TENDER OFFER TO ACQUIRE THE REMAINING SHARES OF ENZYMOTEC PAULSON AGREED TO SUPPORT THE TENDER OFFER AND SELL IN THAT FRAMEWORK ITS REMAINING 9.2...
Record INFAT® Net Revenues of $13.3 Million (Proportionate Consolidation Method) Generated Strong Cash Flow from Operations of $2.9 Million Inventory Write-Off of $3.3 Million MIGDAL...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관